A genetic mutation said she was destined to get Alzheimer’s in her 40s, just like her family members in the Colombian kindred with a rare form of the disease. But remarkably, she experienced no cognitive decline until her 70s. Banner Alzheimer’s Institute was involved in new research that provides an answer for why this happened, which could change the scientific understanding of Alzheimer’s disease and inspire new ideas for prevention.
Banner Sun Health Research Institute: Finger-prick blood test breaks new ground in Alzheimer’s research
Banner Health-led and philanthropy-fueled study enables global research participation Under the leadership of Nicholas Ashton, Ph.D., senior director of the Fluid Biomarker Program at Banner Sun Health Research Institute, an international collaborative effort has...
